{"id":2543768,"date":"2023-05-26T12:11:33","date_gmt":"2023-05-26T16:11:33","guid":{"rendered":"https:\/\/platoai.gbaglobal.org\/platowire\/medtronics-fy23-revenue-reaches-31-2-billion\/"},"modified":"2023-05-26T12:11:33","modified_gmt":"2023-05-26T16:11:33","slug":"medtronics-fy23-revenue-reaches-31-2-billion","status":"publish","type":"platowire","link":"https:\/\/platoai.gbaglobal.org\/platowire\/medtronics-fy23-revenue-reaches-31-2-billion\/","title":{"rendered":"Medtronic’s FY23 Revenue Reaches $31.2 Billion"},"content":{"rendered":"
Medtronic, a global leader in medical technology, recently announced its financial results for the fiscal year 2023. The company reported a revenue of $31.2 billion, which is a 5% increase from the previous year. This growth can be attributed to the company’s strong performance in all of its business segments.<\/p>\n
Medtronic’s Cardiac and Vascular Group, which includes products such as pacemakers and stents, reported a revenue of $11.4 billion, a 4% increase from the previous year. The company’s Minimally Invasive Therapies Group, which includes products such as surgical instruments and respiratory devices, reported a revenue of $10.6 billion, a 6% increase from the previous year. The Restorative Therapies Group, which includes products such as spinal cord stimulators and insulin pumps, reported a revenue of $9.2 billion, a 5% increase from the previous year.<\/p>\n
The company’s strong performance can also be attributed to its focus on innovation and research and development. Medtronic invested $2.3 billion in research and development in FY23, which is a 7% increase from the previous year. The company launched several new products during the year, including the MiniMed 780G insulin pump system and the Hugo robotic-assisted surgery system.<\/p>\n
Medtronic’s CEO, Geoff Martha, stated that the company’s strong performance is a result of its commitment to improving patient outcomes and delivering value to its customers. He also stated that the company is well-positioned for future growth, with a strong pipeline of innovative products and a focus on expanding its presence in emerging markets.<\/p>\n
In addition to its financial performance, Medtronic also made significant contributions to society during the year. The company donated over $100 million in cash and product donations to support COVID-19 relief efforts around the world. The company also launched several initiatives to address health disparities and improve access to healthcare in underserved communities.<\/p>\n
Overall, Medtronic’s FY23 revenue of $31.2 billion is a testament to the company’s strong performance and commitment to innovation and improving patient outcomes. With a focus on research and development and expanding its presence in emerging markets, the company is well-positioned for future growth and continued success.<\/p>\n
Medtronic, a global leader in medical technology, recently announced its financial results for the fiscal year 2023. The company reported a revenue of $31.2 billion, which is a 5% increase from the previous year. This growth can be attributed to the company’s strong performance in all of its business segments. Medtronic’s Cardiac and Vascular Group, […]<\/p>\n","protected":false},"author":2,"featured_media":2527029,"menu_order":0,"template":"Default","format":"standard","meta":[],"aiwire-tag":[925,560,314,3194,11,441,17,18,343,2162,5976,21,5165,23,1493,724,219,1589,966,3186,1773,222,2017,975,12239,5483,590,4106,867,2921,5999,997,1198,233,10856,1748,466,6097,5180,1015,50,51,54,4608,1222,6859,1794,1518,4230,3685,169,1800,57,604,389,170,1034,1426,1427,3262,1644,60,62,484,1901,67,891,396,18798,1659,179,1807,75,78,5454,185,489,263,2033,5,10,7,8,5359,701,629,1813,5658,8903,1542,356,2111,1278,1361,12252,12335,13108,773,1821,1548,496,4179,1285,99,1117,12658,1119,201,101,103,639,11294,23201,781,204,106,108,109,360,9997,111,3320,25834,1730,9,125,362,1308,6],"aiwire":[23161],"_links":{"self":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2543768"}],"collection":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire"}],"about":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/types\/platowire"}],"author":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":0,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2543768\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media\/2527029"}],"wp:attachment":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media?parent=2543768"}],"wp:term":[{"taxonomy":"aiwire-tag","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire-tag?post=2543768"},{"taxonomy":"aiwire","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire?post=2543768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}